The Future Fund investment portfolio

Azadyne Ltd is a pre‑clinical biotechnology company developing novel therapeutics that target autoimmune diseases—including multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease—by leveraging a queuine‑based mechanism, with drug candidates advancing toward first‑in‑human trials.

Jiminny provides a conversation and revenue intelligence platform that records, transcribes and analyzes emails, phone and video calls, delivering AI‑driven insights for sales coaching, pipeline visibility and go‑to‑market strategy. Its customers are revenue leaders, sales managers and teams looking to improve deal conversion and reduce churn.